Titelia

Holdings of Amplify Weight Loss Drug & Treatment ETF

Amplify ETF Trust · 20 declared positions · as of Mar 31, 2026

Original filing · Net assets 4.2M $ · Ten largest lines: 69.9 % of the equity sleeve

Sector breakdown

  • Health care 62.5 %
  • Unattributed 37.5 %

Sector is not declared in Form N-PORT: this is a Titelia classification, decided company by company. The unattributed share is counted as such rather than spread over the others.

Currency breakdown

  • USD 69.9 %
  • HKD 11.2 %
  • JPY 11.0 %
  • CHF 4.7 %
  • DKK 1.8 %
  • KRW 1.3 %

The currency each line is denominated in, as declared. It does not follow the country: a French company listed in the United States is declared in dollars.

Country breakdown

  • US 52.5 %
  • DK 14.3 %
  • HK 11.2 %
  • JP 11.0 %
  • GB 4.9 %
  • CH 4.7 %
  • KR 1.3 %

Shares computed on the equity sleeve, the only part this site carries.

CountryLinesValueShare
US102.1M $52.55 %
DK2565.6K $14.31 %
HK3444K $11.23 %
JP2434.3K $10.99 %
GB1193.3K $4.89 %
CH1185.2K $4.69 %
KR153.1K $1.34 %

Positions

CompanySharesValueWeight
Novo Nordisk A/S 13,431493.6K $11.89 %
Eli Lilly & Co 522480.1K $11.56 %
Regeneron Pharmaceuticals, Inc. 364281.2K $6.77 %
Amgen Inc 740260.4K $6.27 %
Chugai Pharmaceutical Co Ltd 4,600249K $6.00 %
CSPC Pharmaceutical Group Ltd 180,000208.9K $5.03 %
Arrowhead Pharmaceuticals Inc 3,287206.1K $4.96 %
AbbVie Inc 907197.3K $4.75 %
AstraZeneca PLC 980193.3K $4.66 %
Pfizer Inc 6,828191.7K $4.62 %
Merck & Co Inc 1,546186K $4.48 %
Shionogi & Co Ltd 8,500185.3K $4.46 %
Roche Holding AG 473185.2K $4.46 %
Innovent Biologics Inc 17,000184.1K $4.43 %
Scholar Rock Holding Corp 2,00598.6K $2.37 %
Viking Therapeutics Inc 2,81891.7K $2.21 %
Structure Therapeutics Inc 1,73883.8K $2.02 %
Zealand Pharma A/S 1,58472.1K $1.74 %
Hanmi Pharm Co Ltd 15853.1K $1.28 %
Jiangsu Hengrui Pharmaceuticals Co Ltd 6,20051K $1.23 %